Plant Genomics in World Economy

The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital acquired infections is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.

Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives.

Market Size - $11.1 Billion in 2013, Market Growth - CAGR of 10.3% from 2014 to 2020, Market Trends - Growing demand for personalized medicine and the consequent rise in demand for genomics based R&D initiatives is expected to drive market growth during the forecast period

 

- See more at: http://plantgenomics.conferenceseries.com/#section2

The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital acquired infections is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.

Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives.

Market Size - $11.1 Billion in 2013, Market Growth - CAGR of 10.3% from 2014 to 2020, Market Trends - Growing demand for personalized medicine and the consequent rise in demand for genomics based R&D initiatives is expected to drive market growth during the forecast period

 

- See more at: http://plantgenomics.conferenceseries.com/#section2

The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital acquired infections is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.

 

Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives.

Plant Genomics Market Size - $11.1 Billion in 2013, Market Growth - CAGR of 10.3% from 2014 to 2020, Market Trends - Growing demand for personalized medicine and the consequent rise in demand for genomics based R&D initiatives is expected to drive market growth during the forecast period

  • Plant genomics products and analysis
  • Plant genomics innovations in USA
  • Plant genomics research in USA
  • Plant genomics scope in UK
  • Plant Genomics trials in USA and Europe
  • Plant genomics in Asia

Related Conference of Plant Genomics in World Economy

June 19-20, 2017

2nd International Conference on Bioscience

London, UK
July 03-05, 2017

7th World Summit on Plant Genomics

Bangkok, Thailand
July 20-22, 2017

15th Asia-Pacific Biotechnology Congress

Novotel Melbourne St Kilda 16 The Esplanade St Kilda VIC 3182, Au
August 23-24 , 2017

6th International Conference on Tissue Engineering and Regenerative Medicine

San Francisco, California ,USA
August 23-24, 2017

3rd International Conference & Exhibition on Tissue Preservation and Biobanking

(10 Plenary Forums - 1 Event)
San Francisco, California, USA
September 14-15, 2017

2nd World Congress on HUMAN GENETICS

Edinburgh, Scotland
September 21-22, 2017

International Conference on Clinical and Medical Genetics

Toronto, Canada
September 25-27, 2017

17th Euro Biotechnology Congress

Berlin, Germany
September 27-28, 2017

Annual Summit on Cell Therapy and Molecular Medicine


(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 27-28, 2017

Annual Summit on Cell Signaling and Cancer Therapy


(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
October 16-17, 2017

3rd Annual Congress on Bioscience

Dubai,UAE
October 19-20, 2017

18th Biotechnology Congress

New York, USA
October 23-24, 2017

10th World Congress on Stem Cell and Biobanking

Osaka, Japan
October 26-28, 2017

Stem Cells- 2017 (CME & CPD Accredited)

London, UK
November 20-22, 2017

Genomics & Proteomics- 2017 (CME & CPD Accredited)

Rome, Italy
November 27-29, 2017

Transgenomics- 2017 (CME & CPD Accredited)

Frankfurt, Germany
December 04-05, 2017

2nd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil
December 06-07, 2017

Fungal Genetics and Biology

Sao Paulo, Brazil
December 11-12, 2017

3rd World Bio Summit & Expo

Dubai, UAE

Plant Genomics in World Economy Conference Speakers